Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/3/2017
SIETES contiene 91704 citas

 
 
 1 a 20 de 756 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Riesgo de formación de depósitos cerebrales asociado a la administración de agentes de contraste con gadolinio. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:1-3. [Ref.ID 101459]
3.Enlace a cita original
Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol 2016;82:583-623. [Ref.ID 100730]
4. Cita con resumen
Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf 2016;25:1079-87. [Ref.ID 100658]
8. Cita con resumen
Anónimo. Drugs for tobacco dependence. The Medical Letter on Drug and Therapeutics Bulletin 2016;58:27-31. [Ref.ID 100127]
9.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Antidepressants are addictive and increase the risk of relapse. BMJ 2016;352:i574. [Ref.ID 100055]
10. Cita con resumen
11. Cita con resumen
Boussageon R, Gueyffier F, Cornu C. Metformin as firstline treatment for type 2 diabetes: are we sure?. BMJ 2016;352:h6748. [Ref.ID 99967]
12. Cita con resumen
Suissa S, Coulombe J, Ernst P. Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia. Chest 2015;148:1177-83. [Ref.ID 99678]
13. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
14. Cita con resumen
Stammschulte T, Ludwig WD, Mühlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012. Eur J Clin Pharmacol 2015;71:1129-38. [Ref.ID 99553]
15. Cita con resumen
Moncrieff J. Antipsychotic maintenance treatment: time to rethink?. PLOS Medicine 2015;12:4 de agosto. [Ref.ID 99453]
16.Enlace a cita original
Donnerstag N, Schneider TH, Lüthi A, Taeqtmeyer A, Raetz Bravo A, Mehliq A. Severe opioid withdrawal syndrome after a single dose of nalmefene. Eur J Clin Pharmacol 2015;71:1025-6. [Ref.ID 99382]
17. Cita con resumen
Gotzsche PC, Young AH, Crace J. Does long term use of psychiatric drugs cause more harm than good?. BMJ 2015;350:h2435. [Ref.ID 99101]
18. Cita con resumen
Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, Gnjidic D, Del Mar CB, Roughead EE, Page A, Jansen J, Martin JH. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015;175:827-34. [Ref.ID 99080]
19. Cita con resumen
Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness. A randomized clinical trial. JAMA Intern Med 2015;175:691-700. [Ref.ID 99027]
20. Cita con resumen
van Herwaarden N, van der Maas A, Minten MJM, van den hoogen FHJ, Kievit W, van Vollenhoven RF, Bijlsma JW, van den Bemt BJF, den Broeder AA. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ 2015;350:h1389. [Ref.ID 98963]
Seleccionar todas
 
 1 a 20 de 756 siguiente >>